This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Sep 2026 quarter revenue fell 41% to Rs 710.54 lakh; profit rose 30% to Rs 91.82 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts less than its Personal Care peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone quarter ended 30 September 2026: revenue fell 41.2% to Rs 710.54 lakh from Rs 1,209.27 lakh; profit after tax rose 30.1% to Rs 91.82 lakh from Rs 70.58 lakh. Standalone half-year revenue fell 48.0% to Rs 1,047.62 lakh from Rs 2,013.60 lakh; profit after tax fell 4.4% to Rs 127.45 lakh from Rs 133.33 lakh. The profit margin before other income, interest, depreciation and tax rose from 8.4% to 11.8%.
Revenue weakness may pressure the stock, but higher quarterly profit and better margins support sentiment; half-year sales and profit remain lower.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹7.11 Cr | ₹12.09 Cr | −41.2% |
| Operating profit | ₹0.74 Cr | ₹0.90 Cr | −18.2% |
| Profit after tax | ₹0.92 Cr | ₹0.71 Cr | +30.1% |
| EBITDA margin | 11.8% | 8.4% | +3.4 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.